University of Galway has announced the appointment of Dr Finn Krewer as the inaugural holder of the Greally Lectureship in Applied Clinical Data Analytics. The creation of the lectureship and Dr Krewer’s appointment is landmark initiative in integrating advanced clinical data analysis with cutting-edge research in artificial intelligence and healthcare. The Greally Lectureship, endowed on behalf of University graduates Professor John F. and Dr Marie Greally, represents a collaboration between the University’s College of Medicine, Nursing and Health Sciences and the Insight Research Ireland Centre for Data Analytics and confirms ambition to advance clinical research through data-driven innovation. Professor Peter McHugh, Interim President of University of Galway, said: “The creation of the Greally Lectureship and Dr Finn Krewer’s appointment is a significant step in advancing University of Galway’s leadership in Applied Clinical Data Analytics. With the support of Professor John F. and Dr Marie Greally, this lectureship underscores our ambition to harness data-driven innovation to tackle complex healthcare challenges. Dr Krewer’s expertise will play a vital role in realising our vision of transforming clinical research and healthcare delivery through cutting-edge analytics and artificial intelligence.” Dr Marie Greally said: “We are delighted that Dr Krewer will be the first recipient of the lectureship, which we are privileged to have been able to endow as a symbol of the value and excitement of incorporating research into medical practice. We wish him every success and hope it acts as an inspiration to the next generation of students.”   Professor John F Greally said: “Dr Krewer has an extraordinary record of accomplishment already in his career. We look forward to his continued success, applying his skills to clinical data with the goal of improving health care.” Dr Krewer is a graduate of University of Galway and completed his PhD in Engineering in 2017 on bio-inspired reconfigurable computing. His research seamlessly combined biological neuron models with hardware accelerators, earning him numerous university and national scholarships. Since then, Dr Krewer has built a distinguished career, publishing several research papers and gaining industry experience in software development and data analysis. In 2023, Dr Krewer joined University of Galway as a Research Fellow, focusing on applied machine learning techniques for biosignal classification. His current work, supported by a Health Research Board Secondary Data Analysis Project grant, investigates traditional and novel risk factors for stroke in individuals with kidney failure in Ireland. As part of his new role under the Greally Lectureship, Dr Krewer will lead advanced teaching in data analytics and pursue a programme of research addressing clinical data analytics and the applications of artificial intelligence in healthcare.             Professor Martin O’Donnell, Executive Dean of the College of Medicine, Nursing and Health Sciences at University of Galway, said: "Dr Krewer brings exceptional expertise in clinical data analytics and artificial intelligence, which will play a pivotal role in shaping the future of healthcare research. His work will be instrumental in advancing our plans to extend a multi-platform MSc in Applied Clinical Data Analytics, fostering innovations in clinical data analytics and developing our Academic Health Analytic infrastructure. These initiatives aim to bridge traditional and emerging data analysis methods, fostering new insights into mechanisms of disease and advancing population health. We are extremely grateful to Professor John F. and Dr Marie Greally for their generosity.” Ends

Aquila Bioscience developing pathogen decontamination technology for safer space exploration University of Galway spin-out Aquila Bioscience is collaborating with the European Space Agency (ESA) to develop a nature-inspired pathogen decontamination technology for safer space exploration. Traditional antimicrobial measures, while effective on Earth, present significant limitations in space due to potential toxicity, pathogen resistance, and long-term stability concerns. The unique conditions of spaceflight elevate the risk of infectious diseases by altering both human and microbial physiology. Aquila Bioscience’s approach to pathogen decontamination is informed by an extensive review of International Space Station microbiome research, which identified key pathogens posing health risks in confined space environments. These include viruses, bacteria and fungi that cause respiratory, gastrointestinal, urinary and skin infections. Professor Lokesh Joshi, Founder of Aquila Bioscience and Stokes Professor of Glycosciences at University of Galway, said: “Aquila Bioscience is committed to addressing the critical challenges of pathogen exposure in space. Our Pathogen Capturing Technology aligns with the principles of safety, sustainability and innovation that are essential for the future of space exploration. We are honoured to have the European Space Agency’s support as we push the boundaries of innovation. This collaboration underscores the importance of developing sustainable, non-toxic and effective solutions for challenges associated with space exploration.” Aquila Bioscience is pioneering a groundbreaking solution to enhance health and safety protocols for space missions called Pathogen Capturing Technology (PCT). Unlike traditional antimicrobials that may lead to pathogen mutations, sterilisation tolerance, or antimicrobial resistance (AMR), Aquila Biosciences technology provides a safe, effective and eco-friendly alternative that is stable over long periods as space agencies and commercial spaceflight companies strive to ensure the health and safety of their crews. Professor Joshi said: “The deployment of our pathogen control technology in space missions has the potential to revolutionise decontamination protocols, enhancing the safety and well-being of astronauts while supporting sustainable and responsible space exploration.” Aquila Bioscience’s innovative technology employs a selection of natural protein-carbohydrate molecules on a biodegradable matric that act as molecular-Velcro, to capture and remove harmful pathogens without damaging human skin or surfaces. The Pathogen Capturing Technology’s biodegradable composition also addresses critical spaceflight constraints such as payload weight and waste management, ensuring its suitability for long-duration missions. The solution has been inspired by the knowledge of how nature protects humans from germs encountered on a regular basis, offering a non-toxic alternative to conventional decontamination agents like alcohol, bleach, and ammonium compounds, which are often unsuitable for skin use due to their harshness and potential toxicity. The project is sponsored by the European Space Agency (ESA) under ESA Initial Support for Innovation (EISI) activities, funded through the Discovery Programme. Ends

Youth Academy expands and opens more doors for young people to experience university life and engaging learning with researchers and academics University of Galway’s Youth Academy, an outreach programme for high ability students in primary and post-primary school, is launching a new series of courses for spring 2025. The acclaimed initiative for young people offers a unique opportunity for them to explore their passions, develop new skills and experience university life with like-minded pupils. Since its inception in 2012, Youth Academy has welcomed more than 7,000 young people to the campus, inspiring them through innovative, engaging and hands-on activities, and opening their minds to future academic and career possibilities. In spring 2025, the programme will host 23 immersive courses, including 10 new courses, all of which are designed for curious and ambitious young minds, covering science, engineering, coding, languages, philosophy, art, chess and more. The 10 new courses cover cutting-edge subjects like: Biomedical Science, where students will learn about slimy biomaterials and think like a forensic scientist Creative Technologies, where art, artificial intelligence and creativity combine Coastal Engineering, where participants will learn to protect and harness our marine environment, with hands-on activities and real-world solutions These six-week courses for fourth, fifth and sixth-class primary school students and first, second and third-year post-primary school students, will be held on Saturday mornings from February 8th, delivered by expert researchers and educators who are committed to fostering a friendly, inclusive, and supportive learning environment.             Parent Tom Wainwright said: “I like how Youth Academy encourages children to be comfortable making mistakes as part of the learning process and gives them a wonderful opportunity to better understand what university life involves. My son came home telling me about the friends he had made and about courses and career paths we didn’t even know existed.”             Dr Enda O’Connell, Outreach Development Officer managing Youth Academy operations in the Student Recruitment and Outreach Office at University of Galway, said: “We are very excited to present such a diverse range of engaging and impactful courses to inspire young people to try out new subjects, get a taste of campus life and make new friends with similar interests.” Applications are open from Friday January 10th until Thursday January 16th at https://www.universityofgalway.ie/youthacademy/ Eligibility is based on achievement in a student’s most recent English, Maths or Irish standardised test carried out in either primary or secondary school, or on an educational psychologist’s report demonstrating high ability. Through a partnership with Merit Medical, scholarships are provided to 25% of students to attend free of charge, based on economic circumstances. Ends